A Retrospective, Single centre Study Analysing Efficacy, Prognostic Factors, and Safety Profile of Enzalutamide for Non-metastatic and Metastatic Castration-Resistant Prostate Cancer
Latest Information Update: 19 Oct 2020
At a glance
- Drugs Enzalutamide (Primary) ; Flutamide; Gonadotropin releasing hormone
- Indications Bone metastases; Cancer metastases; Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Oct 2020 New trial record
- 10 Oct 2020 Results published in the Targeted Oncology